Sign Up Today and Learn More About Arkose Labs Stock

Invest in or calculate the value of your shares in Arkose Labs or other pre-IPO companies through EquityZen's platform.

Get Started

Arkose Labs Stock

Arkose Labs provides fraud prevention, anti-spam, and abuse analysis for businesses, companies, and industries.

About Arkose Labs Stock

Founded

2017

Headquarters

San Francisco, CA, US

Arkose Labs is an information technology company that focuses on financial services and provides fraud prevention, anti-spam, and abuse analysis for businesses, companies, and industries. Its technology is designed for retail, gaming, and fin-tech. Arkose Labs bankrupts the business model of fraud. Recognized by Gartner as a 2020 Cool Vendor, its innovative approach determines true user intent and remediates attacks in real-time. Risk assessments combined with interactive authentication challenges undermine the ROI behind attacks, providing long-term protection while improving good customer throughput. Founded in Brisbane Australia, and backed by Microsoft, PayPal, and SoftBank Venture Fund 2*, Arkose Labs is hailed by customers as a user-friendly solution to an ever-evolving fraud landscape. Arkose Labs was named by Cyber Defense Magazine as a 2021 “Hot Company in Fraud Prevention”, a Fast Company 2021 “Best World Changing Idea in North America” honoree, and was named by CNBC in their list of the top 100 start-ups to watch in 2019. The company was founded in 2017 and headquartered in San Francisco, California.

Arkose Labs Press Mentions

Stay in the know about the latest news on Arkose Labs

Arkose Labs Management

Leadership team at Arkose Labs

Founder & CEO

Kevin Gosschalk

CMO

Vanita Pandey

Locked Features

Join now and verify your accreditation status to gain access to:

  • Arkose Labs current valuation
  • Arkose Labs stock price
  • Available deals in Arkose Labs and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Arkose Labs stock?

Accredited investors can buy pre-IPO stock in companies like Arkose Labs through EquityZen funds. These investments are made available by existing Arkose Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Arkose Labs stock?

Shareholders can sell their Arkose Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."